Table 7. Sources of Funding for LF Elimination Costs.

National Program	Year	National Government	International Organizations (IDA,NGO,WHO)	Pharma Companies		Community
Percentage of Program Costs (i.e., Financial Costs) for Each Source of Funds
Albendazole+Mectizan
Burkina Faso	2002	39%	61%	0%		<1%
Tanzania	2003	55%	45%	0%		<1%
Albendazole+DEC
Dominican Republic	2003	9%	91%	0%		<1%
Egypt	2000	80%	20%	0%		<1%
Philippines	2003	99%	<1%	0%		<1%
Percentage of Total Costs (i.e., Economic Costs) for Each Source of Funds
Albendazole+Mectizan
Burkina Faso	2002	<1%	<1%	99%		<1%
Tanzania	2003	3%	2%	95%		<1%
Albendazole+DEC
Dominican Republic	1998–2003	46%	42%	9%		3%
Egypt	2000	72.5%	11.5%	16%		<1%
Philippines	2003	48%	3%	46%		3%